MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma

Article Properties
Cite
Xu, Jie, et al. “MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma”. Advances in Clinical and Experimental Medicine, vol. 25, no. 5, 2016, pp. 971-5, https://doi.org/10.17219/acem/36460.
Xu, J., Li, J., & Liu, Z.- jin. (2016). MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma. Advances in Clinical and Experimental Medicine, 25(5), 971-975. https://doi.org/10.17219/acem/36460
Xu J, Li J, Liu Z jin. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma. Advances in Clinical and Experimental Medicine. 2016;25(5):971-5.
Journal Categories
Medicine
Medicine
Medicine (General)
Science
Microbiology
You May Also Like
Citations
Title Journal Journal Categories Citations Publication Date
Study on the Expression of GAB/GBAP1 Gene in Hepatocellular Carcinoma and Its Functional Mechanism of Interaction with miRNAs

 Journal of Biomedical Nanotechnology
  • Technology: Chemical technology
  • Technology: Chemical technology: Biotechnology
  • Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials
 2024
Diagnostic value of multi-slice spiral CT perfusion imaging in primary hepatocellular carcinoma Minerva Medica
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
 2024
The role of microRNA in the development of liver diseases. Part 2

 CHILD`S HEALTH
  • Medicine: Pediatrics
 2023
MicroRNA-155-5p modulates the progression of acute respiratory distress syndrome by targeting interleukin receptors Bioengineered
  • Technology: Chemical technology: Biotechnology
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 4 2022
miR-559 Inhibits Proliferation, Autophagy, and Angiogenesis of Hepatocellular Carcinoma Cells by Targeting PARD3

 Mediators of Inflammation
  • Medicine: Pathology
  • Science: Biology (General): Cytology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 6 2022
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)19
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens10
Science: Biology (General)9
Medicine: Therapeutics. Pharmacology7
Medicine: Public aspects of medicine: Toxicology. Poisons6
Science: Chemistry: Organic chemistry: Biochemistry5
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology3
Technology: Chemical technology: Biotechnology3
Medicine: Internal medicine2
Science: Biology (General): Cytology2
Science: Biology (General): Genetics2
Medicine: Medicine (General): Medical physics. Medical radiology. Nuclear medicine2
Geography. Anthropology. Recreation: Environmental sciences1
Technology: Environmental technology. Sanitary engineering1
Science: Biology (General): Ecology1
Medicine1
Science1
Science: Science (General)1
Science: Chemistry: Organic chemistry1
Science: Chemistry: General. Including alchemy1
Science: Chemistry1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system1
Medicine: Gynecology and obstetrics1
Science: Biology (General): Reproduction1
Medicine: Pathology1
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy1
Medicine: Internal medicine: Specialties of internal medicine1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology1
Technology: Chemical technology1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Medicine: Medicine (General): Medical technology1
Medicine: Pediatrics1
The category Medicine: Medicine (General) 19 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma and was published in 2017. The most recent citation comes from a 2024 study titled Study on the Expression of GAB/GBAP1 Gene in Hepatocellular Carcinoma and Its Functional Mechanism of Interaction with miRNAs. This article reached its peak citation in 2019, with 8 citations. It has been cited in 30 different journals, 43% of which are open access. Among related journals, the Frontiers in Oncology cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year